Influenzinum (2024-2025)
Influenzinum (2024-2025) is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Influenzinum 200C. Available dosage form: liquid.
Drug details
- Generic Name
- Influenzinum (2024-2025)
- Brand Names
- Influenzinum 200C
- Sponsor
- Energique, Inc.
- NDC Codes
- 1
- Dosage Forms
- LIQUID
- Routes
- ORAL
- Active Ingredients
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE
Indications and Usage
USES: May temporarily relieve symptoms associated with the flu: •aches •pains.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Warnings
WARNINGS: Stop use and ask a doctor if symptoms persist for more than 3 days. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN OR MISSING. Store in a cool, dry place.